High frequency of dyslipidemia in HIV-infected patients in a Peruvian public hospital

Authors

  • Paola L. Rondan Servicio de Enfermedades Infecciosas y Tropicales, Hospital Nacional Dos de Mayo. Lima, Perú. Facultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia. Lima, Perú. Médico cirujano
  • Oscar Flores-Flores Servicio de Enfermedades Infecciosas y Tropicales, Hospital Nacional Dos de Mayo. Lima, Perú. Facultad de Medicina Humana. Universidad de San Martín de Porres. Lima, Perú. Médico cirujano
  • Nicole A. Doria School of Medicine, The George Washington University. Washington D.C., EE.UU. estudiante de Medicina Humana
  • Gustavo Valencia-Mesias Servicio de Enfermedades Infecciosas y Tropicales, Hospital Nacional Dos de Mayo. Lima, Perú. Médico cirujano
  • Víctor Chávez-Pérez Servicio de Enfermedades Infecciosas y Tropicales, Hospital Nacional Dos de Mayo. Lima, Perú. Universidad Nacional Mayor de San Marcos, Lima, Perú. médico infectólogo
  • Jaime Soria Servicio de Enfermedades Infecciosas y Tropicales, Hospital Nacional Dos de Mayo. Lima, Perú. médico infectólogo

DOI:

https://doi.org/10.17843/rpmesp.2017.342.2587

Keywords:

Dyslipidemias, HIV, Antiretroviral therapy, highly active

Abstract

The objective of the study was to determine the frequency and characteristics of dyslipidemia in patients with HIV in highly active antiretroviral therapy (HAART) in a Peruvian public hospital. A cross-sectional study was carried out in patients with complete lipid profile after receiving at least six months of HAART. Dyslipidemia was defined according to the criteria of the NCEP-ATP III. We reviewed 2 975 clinical histories, and included 538 (18.1%) in the analysis. The frequency of dyslipidemia was 74.7%. HAART regimens which include protease inhibitors (PI) (odds ratio [OR]: 1.22; confidence interval at 95% [CI 95%]: 1.11-1.33) and to be older than 40 years (OR: 1.17; CI 95%: 1.05-1.28) were associated with dyslipidemia, adjusted by viral load, CD4  lymphocyte level and gender. In conclusion, dyslipidemia was very common in our sample and was mainly associated with the use of PI. It is necessary to promote the dyslipidemia control as part of the comprehensive care of the patient with HIV.

Downloads

Download data is not yet available.

Author Biography

  • Paola L. Rondan, Servicio de Enfermedades Infecciosas y Tropicales, Hospital Nacional Dos de Mayo. Lima, Perú. Facultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia. Lima, Perú. Médico cirujano
    Médico Cirujano investigador de la Unidad de Investigación Clínicas del Servicio de Enfermedades Infecciosas y Tropicales

Published

2017-06-28

Issue

Section

Brief Report

How to Cite

1.
Rondan PL, Flores-Flores O, Doria NA, Valencia-Mesias G, Chávez-Pérez V, Soria J. High frequency of dyslipidemia in HIV-infected patients in a Peruvian public hospital. Rev Peru Med Exp Salud Publica [Internet]. 2017 Jun. 28 [cited 2024 Mar. 28];34(2):239-44. Available from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/2587

Most read articles by the same author(s)